[A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Two patients who had advanced gastric cancer and metastatic liver tumors were treated with a combined chemotherapy using UFT and mitomycin C. A marked reduction in the size of primary gastric cancer and metastatic liver tumors was observed, and the response continued for more than 6 months after the initial treatment in these cases.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D008937:Mitomycins; D005641:Tegafur; D016685:Mitomycin; D014498:Uracil